PHARMCO I ApS: Financial statements 2024
CVR: 25204042
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
PHARMCO I ApS (CVR 25204042) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -98,000 and a net result of DKK 44,804,000 compared with DKK 32,297,000 the year before. Equity in the 2024 report amounted to DKK 409,700,000. The solvency ratio was 98.1%. The company had 440 employees in the financial year.
- Revenue
- DKK 0
- Gross Profit
- DKK -98,000
- Profit/Loss
- DKK 44,804,000
- Equity
- DKK 409,700,000
- Total Assets
- DKK 417,714,000
- Employees
- 440
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | 0 | -98 t. | 44.8 mio. | 409.7 mio. | 440 |
| 2023 | 0 | -112 t. | 32.3 mio. | 364.6 mio. | 416 |
| 2022 | 0 | -72 t. | 17.5 mio. | 332.8 mio. | 425 |
| 2021 | 0 | -69 t. | 43.2 mio. | 316.3 mio. | 420 |
| 2020 | 0 | -82 t. | 36.1 mio. | 272.5 mio. | 394 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
PHARMCO I ApS has published its annual report for 2023. Revenue came to DKK 0, and the net result was DKK 32,297,000.
About PHARMCO I ApS
PHARMCO I ApS is a Danish company of the type Anpartsselskab based in Vojens, founded in 2000. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Eli Wallin. The company is owned by Eli Wallin. According to the 2025 annual report, the company had an average of 473 employees. In 2025, the company reported a gross profit of DKK -105,000 and a net result of DKK 92,326,000 compared with DKK 44,804,000 the year before. Equity in the 2025 report amounted to DKK 469,411,000.